Obalon Announces Fourth Quarter and Full Year 2020 Financial Results
12 mars 2021 19h12 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
OBALON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OBLN and Encourages Investors to Contact the Firm
22 janv. 2021 16h46 HE
|
Bragar Eagel & Squire
NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
Obalon Announces Third Quarter 2020 Financial Results
06 nov. 2020 16h45 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
13 août 2020 07h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces Second Quarter 2020 Financial Results
30 juil. 2020 06h38 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces First Quarter 2020 Financial Results and Business Update
19 juin 2020 06h15 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
11 mai 2020 08h30 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
08 mai 2020 08h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons
28 avr. 2020 09h00 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Engages Canaccord Genuity to Explore Financial and Strategic Alternatives
25 mars 2020 08h30 HE
|
Obalon Therapeutics, Inc.
SAN DIEGO, March 25, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...